NDC Pharmacologic Class N0000190478 Interleukin 6 Receptor Antagonists [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0024-5908Kevzara SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5910Kevzara SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5920Kevzara SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5922Kevzara SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
50242-135Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.Human Prescription Drug
50242-136Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.Human Prescription Drug
50242-137Actemra TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.Human Prescription Drug
50242-138Actemra TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.Human Prescription Drug
50242-143Actemra Actpen TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.Human Prescription Drug

There are 9 NDC products with the pharmacologic class Interleukin 6 Receptor Antagonists [MoA].